Abstract: tRNA was extracted from brains of 3-, 8-, and 18-day-old rats that were injected intracerebrally, 45 min before death, with [3H]methyl methionine or [8-:'H]guanosine, and intraperitoneally, 3 h before death, with Lrnethionine-dl-sulfoximine (MSO), a methylation-activating convulsant agent. Although there was no effect of age or of MSO on the per gram yield of tRNA, its specific radioactivity (dpm/A,,,) was highest at 3 days in both the control and the MSO groups. Age-and MSO-related changes in the tRNALYs content of the brain tRNA pool were investigated by means of benzoylated DEAEcellulose (BDC) and reverse-phase chromatography (RPC). BDC chrornatography revealed tRNALys species in the brains of the MSO-treated animals that were absent in control brains. Of particular interest was the finding that differences in RPC-5 chromatographic mobility between control and MSO-tRNA',ys species were abolished by conversion to lysyl-tRNA, suggesting that the MSO-elicited chanye(s) in tRNAL"" structure involved the binding site(s) for lysine. Two additional findings were made: (a) lysine acceptance by the [3H]methyl-labeled tRNALys purified from brains of the MSO-treated animals was higher than that of controls at 18 days; and (b) omission of the BDC chromatographic step accentuated the differences in mobility on RPC-5 columns between tRNA'.Ys species of control and MSO-treated brains. Lastly, we found that some tRNA'.ys species present in the MSO-treated brains contained significantly different proportions of N2-methyl guanine and 1-methyl adenine, relative to controls. These MSO-elicited changes in the methyl base content of tRNALss of immature rat brain are the first evidence of an alteration of brain tRNA structure by a centrally acting excitatory agent.
Over the past few years, work from our laboratory has shown that immature brain tRNAs are subject to the action of homologous tRNA methyltransferases (Cummins et al., 1975) which convert them into mature tRNA molecules postnatally (Salas et al., 1976; Elahi and Sellinger, 1979) , and that this process continues for as long as a month and a half. The analysis of [3H]methyl-tRNAs formed by 3-and 18-day-old rat brain revealed 10 different [3H]-N-methyl bases in the newly formed [3H]tRNA Dainat et al., 1978; Elahi and Sellinger, 1979) . More recently, we f o u n d that the nature of the [3H]methyl-tRNA base varies in different neural cell types. In the cerebellum o f the rat (Dainat and Sellinger, 1980) , ["HI-N2-methyl guanine was the predominant tRNA ['Hlmethyl base formed throughout the first 43 days of life; in glial astrocytes tested after 19 days in culture (Cummins and Glover, 1979) and 1-8 h of exposure to ["Hlguanosine, the principal t R N A [3H]methyl guanine was 7-methyl guanine (Sellinger and Der, 1981) ; whereas in the 3-day-old rat, the newly formed [3H] tRNA contained equal proportions of [7-"]- and [3H]-N2-methyl guanine and had no [l-3H] methyl guanine (Sellinger and Der, 1980) .
Parallel in vitro studies have disclosed that neural tRNA methyltransferases undergo age-dependent changes in specificity (Salas e t al., 1976; Dainat and Sellinger, 1980) and that they acquire their adult specificity patterns only gradually, presumably via temporally evolving mechanisms designed to commit them eventually to recognize only their cognate tRNAs. Recently, however, we documented three different instances of "aberrant" interaction between the tRNA methyltransferase protein of neural cells and heterologous tRNA: (a) in the cerebellum of the icteric Gunn rat (Dainat e t al., 1979) ; (b) in the brain of the Sprague-Dawley albino rat following a single dose of the convulsant agent L-methioninedl-sulfoximine (MSO; Salas et al., 1977; Dainat et al., 1978) ; and (c) in cultured glial astrocytes briefly exposed to MSO (Sellinger and Der, 1981) .
In the present report we describe further MSOelicited modifications in the in vivo methylation of immature brain tRNA (Der and Sellinger, 1980) by focusing on the synthesis of an individual tRNA species. tRNALYS appeared especially suited for this purpose, for its purification (Raba e t al., 1979) , its numerous, readily separable isoacceptors (Ortwerth et al., 1973; Chu-Der and Ortwerth, 1979) , and its content of up to five methyl baseslmole (Raba et al., 1979; Sprinzl et al., 1980) have been described in detail in nonneural systems. In addition, tRNALYs has been shown to exhibit typical developmental fluctuations in its isoacceptor composition that appear t o relate directly t o cell division (ConlonHollingshead and Ortwerth, 1980) , cell differentiation (Kleiman et al., 1978; Lin and Agris, 1980 ), growth (Chu-Der and Ortwerth, 1979 , and proliferation ( J u a r e z e t a l . , 1975; Marini a n d Mushinski, 1979) .
EXPERIMENTAL PROCEDURES Animals
The 3-, 8-, and 18-day-old rats were of the SpragueDawley strain. The 3-day-old animals were used at the earliest 24 h after arrival from the shippers (Spartan Farms, Haslett, MI). They were housed in cages containing 1 familykage. sodium EDTA, 10 mM P-mercaptoethanol, and 0.05% DEPC. The homogenate was centrifuged for 20 min at 30,000 x g ; the low-molecular-weight RNA was extracted from the resulting supernatant by the procedure of Ortwerth and Chu-Der (1974) .
Chemicals

Purification, hydrolysis, and compositional analysis of t RNALYs
Following extraction, the RNA was precipitated with ethanol and stored overnight at -20°C. Following centrifugation, it was redissolved in 10 mM Tris-HC1, containing 10 m M MgClz, 1 mM EDTA, and 50 mM NaCI, pH 7.5 (buffer A), and the sample was loaded on a column of DEAE-cellulose previously equilibrated with buffer A. Elution with buffer A was continued until the AZ6,, reading reached a value of 0.05, at which time the tRNAcontaining fraction was stripped with 0.7 M NaCl in buffer A. The tubes with A26dAzso values above 1.5 were pooled and dialyzed to remove NaCI. Following lyophilization, the tRNA was hydrolyzed (Klagsbrun, 1972) Salas and Sellinger (1977) . Since, however, it was determined in preliminary experiments that brain ["] 
BDC chromatography
Cellex-BD was washed and the column (0.7 X 20 cm) was packed and prepared for use according to Roy et al. (1971) . The equilibrating buffer was 50 mM sodium acetate, pH 5.0, containing 10 mM MgC1, and 0.3 M NaCI. tRNA, dissolved in the equilibrating buffer, was loaded, and the elution was carried out with 120 ml of a 0.5-1 .OM NaCl gradient in the above buffer. The flow rate was adjusted to 2 mumin and 5-ml fractions were collected. All solutions used in BDC chromatographic work also contained 0.04% sodium azide. Aliquots (0.1 ml) of each emuent fraction were mixed with scintillant and their radioactivity was determined. Up to 0.5 ml was taken for the aminoacylation assay (see below).
RPC-5 chromatography
The procedure described by Kelmers and Heatherly (1971) was adapted to a 0.9 x 50-cm column which was operated at approximately 250 psi. Elution was carried out using 200 rnl of a gradient of 0.5-or 0.6-1 .O M NaCl prepared in 10 mM sodium acetate, 10 mM MgClz, 1 mM EDTA, and 30 mM P-mercaptoethanol, pH 4.5.
Preparation of aminoacyl-tRNA synthetases
Livers of adult rats were homogenized in 2 volumes of buffer containing 0.25 M sucrose, 50 mM KCI, 10 mM Tris-HCI ( p H 7.5), 10 mM MgCI,, 0.01 rnM Pmercaptoethanol, and 10% (voUvol) glycerol. The remainder of the procedure was as described in a previous report (Sellinger and Der, 1980) .
tRNA aminoacylation
Afrer chromutography o n BDC or RPC-5 (postcharging). tRNA was arninoacylated in a reaction volume of 1 ml containing 1 pCi of [I4C]lysine, 0.4 M Tris-HCI (pH 7.5), 10 mM MgCI2, 20 mM KCI, 1 mM ATP, 0.6 mM CTP, 2 mM P-mercaptoethanol, up to 0.5 ml of effluent, and approximately 1 mg of arninoacyl-tRNA synthetase protein. Following incubation for 10 min at 37°C with gentle shaking, the reaction was stopped by placing the tubes on ice, adding 5 ml of ice-cold 10% trichloroacetic acid, and collecting the radioactive lysyl-tRNA on Whatman GF/A filters, processed for counting according to Yang and Novelli (1971) .
Bejore chromatography on RPC-5 (precharging). This was carried out on amounts of tRNA in excess of 1 A,,, unit in a final volume of 5 ml, containing 5 pCi of [ ' T I -or ["Hllysine, 0.2 M Tris-HCI (pH 7.5), 10 mM MgCl,, 20 mM KCI, 1 mM ATP, 3 m M CTP, 8 mM 8-mercaptoethanol, and 10-15 mg of aminoacyl-tRNA synthetase protein. After incubation at 37°C for 20 min, the incubation mixture was passed through a column of DEAE-cellulose (5-ml bed volume), followed by SO ml of buffer A, 30 ml of buffer A that was 0.5 M in NaCI, and finally, to elute lysyl-tRNA, 40 ml of buffer A that was 0.7 M in NaCI. Aliquots of the eluate were removed for counting; 10 A,,, units of adult liver tRNA was added as carrier and total tRNA was precipitated by the addition of 4 volumes of 100% ethyl alcohol (EtOH). The tRNA was collected after overnight storage at -20°C by filtration over 0.45-p Millipore filters and was suspended in 1 ml of RPC-5 buffer (see above).
Protein determination crystalline bovine serum albumin as standard. 
RESULTS
The effect of MSO and age on the yield a n d the radioactivity of brain ["HItRNA ["HItRNA was prepared from the brains of 3-, 8-, and 18-day-old rats, following a 45-min pulse of [3H]methyl-~-methionine; [8-3H] guanosine was administered to 18-day-old animals a s well. The amounts of DEAE-purified, EtOH-precipitated tRNA obtained from widely different initial brain weights are shown in Table 1 , together with comparative information on the labeling of this fraction.
The yield of tRNA in the range of 3.0-3.7 A,,, units/g was not affected by either the MSO treatment or age. Equally similar were the two total radioactivity (dpm x lop5) values following methionine; following guanosine, however, the total radioactivity of the MSO-[3H]tRNA fraction was about half that of the control ["ItRNA.
Brain tRNA became significantly labeled at all ages, even though in the several experiments carried out, the absolute yield of tRNA ranged from a low of about 10 units (8 3-day-old brains) to a high of about 140 A,,, units (32 18-day-old brains). Additionally, Table 1 shows that following the 45-min pulse, the specific radioactivity (SRA) of ['HItRNA was highest at 3 days.
Effect of MSO on tRNA'? BDC chromatography
The identification of tRNALy5 within the tRNA pool of developing rat brain was carried out by BDC chromatography, followed by assay of effluent aliquots for lysine acceptance activity. The BDC profile of tRNALYS in control and MSO-treated brains at 3, 8, and 18 days ( Fig. 1) shows two control species at all three ages, the early eluting species being the major one. An additional tRNALs5 species was detected in the 8-and 18-day MSO profile. The 3-day MSO profile did not show this additional tRNA'.s', yet the magnitude of the two existing tRNALyS peaks was inverted vis a vis the controls, the late eluting peak being the major one in this case. To determine if the additional tRNALYs found in the 18-day-old MSO brain represents a species absent in the control brain, MSO tubes 2-6 and control tubes 12-18 ( Fig. 1) were pooled, the total tRNA was EtOH precipitated, collected, suspended, and rechromatographed. Figure 2 shows the clear resolution of two tRNALYS peaks, each coincident with a peak of absorption at 260 nm. These findings demonstrate that the administration of MSO resulted in the emergence of a chromatographically distinct tRNALYS species in the brain of the 18-day-old rat. When the two tRNALYs species, shown as separate entities in Fig. 2 , were first precharged, MSO-tRNA with [3H]lysine and control tRNA with [14C]lysine, and were then rechromatographed as charged species, their resolution could no longer be achieved (Fig. 3) . This finding indicates that the structural differences that accounted for their distinct chromatographic behavior in the uncharged form (Fig. 2) were wiped out upon reaction with lysine to form lysyl-tRNA.
RPC-5 chromatography
The major brain tRN-ALYS species identified by BDC chromatography were further purified by RPC-S chromatography (Fig. 4) . At 3 days, the control RPC-5 profile of tRNALYs (tubes 5-13, Fig.  1 ) displayed a late eluting species that was not detected in the MSO profile (tubes 10-14, Fig. 1 ). The unique MSO-tRNAL"' at 8 days (tubes 6-10, Thirty-four control and 11.6 MSO units were loaded on a fresh BDC column. Elution was with 80 ml of a 0.3-1.0 M NaCl gradient, prepared in the buffer described in Experimental Procedures, and 3.5 ml/tube was collected. (0) gave rise to the complex tRNALYs profile shown in Fig. 4B whereas the main 8-day tRNALYS species (control tubes 10-14 and MSO tubes 12 and 13, Fig.  1 ) resulted in the relatively simple, as well as similar, profiles of Fig. 4C . Figure 4D and E illustrate tRNA',Ys in the 18-day-old brain' after BDC (D) and after DEAE, omitting BDC (E). It may be seen that differences between the tRNALYs profiles of control and MSO brains became accentuated in the latter situation.
The labeling of brain tRNALyS: Effects of age and MSO Since brain tRNA becomes significantly labeled within 45 min after the intracerebral administration of its precursor, be this [3H]methyl methionine (Saborio and Aleman, 1970;  Dainat et al., 1978) or [3H]guanosine (Sellinger and Der, 1980), we used this pulse time in the present study. The SRA of tRNALYS (dpm/Azso) and the effects of the MSO treatment and age on it are shown in Table 2 . At 3 days, the two tRNALyS species clearly resolved by BDC chromatography (in an experiment similar to that resulting in the profile shown in Fig. 1 ) became markedly, albeit similarly, labeled in the control and
~~
The tRNALYS was obtained by BDC chromatography in an experiment other than that depicted in Fig. 1 but which MSO-treated brains, with the minor component (tubes 16-20, -21) exhibiting twice the SRA of the major tRNALY' species (tubes 8-14). At 8 days, the two principal tRNALYS species, common to both the control and the MSO-treated brains, became labeled to an approximately equal extent, yet the control species reached significantly higher SRA values. The tRNALYS species detected only in the MSO-treated brains (BDC tubes 6-10, Fig. 1 ) was the least heavily labeled, yet, as shown by the dashed line profile of Fig. 4B , its further purification by RPC-5 chromatography gave rise to a radioactivity profile that matched the tRNALYs acceptance activity quite reasonably. At 18 days, following [3H]methyl methionine (Table 2A) , the initial DEAE fraction as well as the two main tRNA'*Ys species contained in the RPC-5 tubes, as indicated, became labeled to a similar extent. When [3H]guanosine was used (Table 2B) , the SRA values of the purified tRNALYS species were significantly lower than after [3H]methyl methionine.
The effect of MSO on the acceptance capacity of brain tRNALYS A series of preliminary experiments was conducted in which differences in lysine acceptance capacity between the brain tRNA of control and MSO-treated rats were sought. In these experiments, we compared: (a) the initial acceptance rates (1 mg protein) aminoacyl-tRNA synthetase and with incubation for 5 and 45 min. No consistent differences in lysine acceptance were uncovered between the relatively crude "bulk" brain tRNA preparations isolated, respectively, from 3-day-old control and MSO-treated animals (see, however, Der and Sellinger, 1980) . However, we consistently noted a higher acceptance activity for the "MSO species" using 18-day-old, RPC-5-purified tRNALY' (Table 3) , particularly after [3H]methionine.
The methylation of brain tRNALY': Effects of MSO
The principal tRNALYS species were hydrolyzed (Figs. 1 and 4) , their [3H]methyl bases were separated by HPLC, and their radioactivity was determined. The three major [3H]methyl bases found present in all hydrolysates of brain tRNALYS were 1-methyl adenine, 7-methyl guanine, and A''-methyl guanine, a finding in accordance with the known sequences of mammalian tRNA' Y s (Sprinzl et al., 1980) . Their sum was normalized to loo%, and the percent of each in the different tRNALY' species isolated from control and MSO-treated brains was calculated ( Table 4) . Supplementary findings were expressed as ratios of [3H]methyl bases, with two of them demonstrating effects of MSO on tRNA'AYs methylation. Four instances of such effects were encountered: (a) a virtual doubling of the N2-methyl guanine to 1-methyl adenine ratio in the main MSO-tRNAIsY' species at 3 days, (b) a virtual doubling of the N2-methyl guanine to 7-methyl guanine ratio in the predominant MSO-tRNA'Y' at 8 days, coupled to (c) a corresponding 90% reduction of the N2-methyl guanine to 1-methyl adenine ratio, and (d) a 50% increase in the N2-methyl guanine to 1-methyl adenine ratio in the early eluting MSOtRNALvS species (Fig. 4E) at 18 days. (Fig. 1) were pooled, and their tRNALYs composition determined in two separate and consecutive chromatographic runs. The A , , , units loaded onto the RPC-5 columns were 2.7 and 2.9 for the control and the MSO samples, respectively. B: The contents of tubes 6-10,4.0 A , , , units and 13,572 [3H] dpm, (Fig. 2, MSO, 8 days) were chromatographed. Solid line, [14C]Lysine acceptance; dashed line, [3H]-radioactivity. C: As in B, except that the contents of tubes 10-14 (control) and 12 and 13 (MSO) of Fig. 1 (8 days) were chromatographed. Inset shows the [3H]-radioactivity profile, following labeling of the animals with [3H]methyl methionine. Note different ordinate scales for control and MSO samples; 11.7 (control) and 7.2 (MSO) A, , , units, containing 72,468 and 31,176 dpm of [3H] were loaded on each of two identical columns. D: The principal tRNALYs peak, obtained by BDC chromatography in an experiment analogous to that shown in Fig. 1 (18 days) , was chromatographed. 39.8 and 52.1 A, , , units of control and MSO material were loaded, and the acceptance of [14C]lysine was determined in the eluates. E: tRNALYs was chromatographed immediately following the DEAE-cellulose purification step, omitting BDC chromatography. 11.6 (control) and 12.7 (MSO) A , , , units were loaded onto each of two identical columns.
DISCUSSION
In the present study, we continue to characterize the changes in the tRNA pool of rat brain during early postnatal development, a time when the many tRNA-processing and -modifying enzymes, actively at work (Elahi and Sellinger, 1979) , are particularly vulnerable to a variety of environmental influences (Cummins et a]., 1975; Salas et al., 1976 Salas et al., , 1977 Sellinger et al., 1977; Dainat et al., 1978 Dainat et al., , 1979 Sellinger and Der, 1981) . Our results regarding the tRNA content of rat brain (Table 1) in the 3-to 18-day postnatal period show values of approximately 0.15 mglg (1 A,,, unit = 45 p g of tRNA), matching those previously reported by Harris and Maas (1974) . Table 1 also shows that within the range of brain weights tested (3-43 g), the yield of tRNA was relatively independent of their initial value.
The BDC profiles of tRNALYs (Fig. 1) are the first, to our knowledge, of individual tRNA species in the 0. Z . SELLfNGER 
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Control peak not detected.
[3H]Guanosine was injected.
developing rat brain. Previously, tRNA isoacceptor species have been examined by RPC chromatography in adult calf (Murthy et al. 1974; Borkowski and Brzuskiewicz-Zarnowska, 1975) , goldfish (Kaplan and Sirlin, 1975) , and mouse brain (Frazer and Yang, 1972; Marini and Mushinski, 1979) . Only For experiment A, see RPC-5 profile of Fig. 4E ; for experiment B, the RPC-5 profile closely resembled that shown in Fig.   4D . A and B of this 18-day-old rats were used.
* Numerals refer to the RPC-5 effluent tubes containing the tRNA species tested for ['4C]lysine acceptance. Frazer and Yang (1972) and Marini and Mushinski (1979) have reported more than one tRNALyS species.
The use of BDC rather than RPC-5 chromatography for the initial survey of the tRNALYS-isoaccepting species of developing rat brain and for the detection of MSO-elicited changes in its structure ( Fig. 1) was prompted mainly by the reported inability of RPC-5 chromatography to reveal any major structural alterations between tRNA from normal and ethionine-treated rats (Ginzburg et a]. , 1979) . A further incentive to use BDC was the high discriminatory power of this technique for revealing differences between uncharged and charged tRNA-isoaccepting species, which allowed Meza et al. (1977) to detect a tRNA*la isoacceptor under conditions where the analysis of charged species missed it. As may be noted by inspection of Fig. 1 , the choice of BDC over RPC-5 proved fortunate, since it led to the discovery of uncharged tRNA'AYS species emerging after MSO and not detected among the control tRNAs (Figs. 2 and 3) .
The loss of the difference in mobility on BDC columns between tRNALYs-isoaccepting species of control and MSO-treated animals that occurred upon lysyl-tRNA formation (Fig. 3 ) is at present difficult to interpret. Yet, obviously, this result implies that the MSO-elicited modification(s) in tRNALYs structure does not contribute to define the I-mA, I-Methyl adenine; 7-rnG, 7-methyl guanine; N2-mG, N2-methyl guanine; C, control; M, MSO. " There was no early eluting C peak (see Fig. 1, 8 days) .
* RPC-5 chromatography followed the DEAE purification step; BDC chromatography was omitted (see Fig. 4E ).
mobility of lysyl-tRNA; hence it (they) must reside at or close to the many sites that are apparently important for synthetase-tRNA interactions (Schimme1 and Soll, 1979) and that become occupied when this interaction is completed. The characterization of the tRNALYs site(s) modified by MSO must await the rigorous purification of the tRNALYS species involved (Raba et al., 1979) and the comparison of its (their) interaction in vitro (relative to that of control tRNALYs species) with the purified rat liver lysyl-tRNA synthetase recently dissociated successfully from the 24s aminoacyl-tRNA synthetase complex containing the lysyl-, leucyl-, and arginyl-tRNA synthetase activities (Johnson et al., 1980) . RPC-5 chromatography of the major BDCtRNA',Ys species failed to enhance the separation of control species from any species putatively modified by MSO; yet, as shown in Fig. 4E , a clear discrimination between control and MSO-tRNALYs species could be achieved by omitting BDC chromatography and applying RPC-5 chromatography immediately after the DEAE-cellulose purification step. The effects of MSO on the labeling of tRNALYS and on its functional capacity revealed a marked increase in the apparent acceptance capacity of [3H]tRNALYs after [3H]methyl methionine, whereas after [YH]guanosine, its acceptance capacity remained relatively unchanged. An increase in the acceptance capacity of rat liver tRNAMe' was recently stated to be the result of the formation of "active intermediates (which) apparently modify tRNA and thus enhance its acceptance for methionine" (Hradec et al., 1979) . Ginzburg et al. (1979) described changes in rat liver tRNA acceptance following the administration of ethionine; these included a decreased capacity for phenylalanine, an increased capacity for histidine, and no change in acceptance for leucine. Three putative causes of these changes were enumerated: ethylation of tRNA, its undermethylation-altered processing, and/or changes in its conformation. As shown in Table 4 , the major MSO-tRNALYS species in the 18-day-old brain (Fig. 4E, Table 3A) had twice the lysine acceptance activity of the corresponding control species, a 52% increase in its N2-methyl guanine to 1-methyl adenine ratio, and an increased N2-methyl guanine content (from 33.9-41.9%). Yet, as Table 3 also shows, the acceptance activity of the minor MSOtRNALYS species increased by 51%, despite no change (Table 4) in its N2-methyl guanine to 7-methyl guanine and 1-methyl adenine ratios. A similar, but less pronounced, increase in acceptance by the major MSO-tRNALYS (Table 3B ) was also seen following [3H]guanosine. These observations suggest that the magnitude of the change in lysine acceptance is dependent on changes in the rnethylation of guanine and adenine , and not of guanine alone. The present results give further credence to our previous claim that MSO stimulates a set of N2-guanine-tRNA methyltransferases Dainat et al., 1978; Sellinger and Der, 1981) to insert a methyl group(s) into specialized subpopulations of tRNALYS isoacceptors (Hatfield et al., 1980; Hedgcotb et al., 1980) 
